Literature DB >> 21220768

Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China.

Hongjie Yu1, Zijian Feng, Timothy M Uyeki, Qiaohong Liao, Lei Zhou, Luzhao Feng, Min Ye, Nijuan Xiang, Yang Huai, Yuan Yuan, Hui Jiang, Yingdong Zheng, Paul Gargiullo, Zhibin Peng, Yunxia Feng, Jiandong Zheng, Cuiling Xu, Yanping Zhang, Yuelong Shu, Zhancheng Gao, Weizhong Yang, Yu Wang.   

Abstract

BACKGROUND: Data on risk factors for severe outcomes from 2009 pandemic influenza A (H1N1) virus infection are limited outside of developed countries.
METHODS: We reviewed medical charts to collect data from patients hospitalized with laboratory-confirmed 2009 H1N1 infection who were identified across China during the period from September 2009 through February 2010, and we analyzed potential risk factors associated with severe illness (defined as illness requiring intensive care unit admission or resulting in death).
RESULTS: Among 9966 case patients, the prevalence of chronic medical conditions (33% vs 14%), pregnancy (15% vs 7%), or obesity (19% vs 14%) was significantly higher in those patients with severe illness than it was in those with less severe disease. In multivariable analyses, among nonpregnant case patients aged ≥ 2 years, having a chronic medical condition significantly increased the risk of severe outcome among all age groups, and obesity was a risk factor among those <60 years of age. The risk of severe illness among pregnant case patients was significantly higher for those in the second and third trimesters. The risk of severe illness was increased when oseltamivir treatment was initiated ≥ 5 days after illness onset (odds ratio, 1.42; 95% confidence interval, 1.20-1.67). For persons <60 years of age, the prevalence of obesity among case patients with severe illness was significantly greater than it was among those without severe illness or among the general population.
CONCLUSIONS: Risk factors for severe 2009 H1N1 illness in China were similar to those observed in developed countries, but there was a lower prevalence of chronic medical conditions and a lower prevalence of obesity. Obesity was a risk factor among case patients < 60 years of age. Early initiation of oseltamivir treatment was most beneficial, and there was an increased risk of severe disease when treatment was started ≥ 5 days after illness onset.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220768      PMCID: PMC3060897          DOI: 10.1093/cid/ciq144

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

1.  Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010.

Authors:  R G Pebody; E McLean; H Zhao; P Cleary; S Bracebridge; K Foster; A Charlett; P Hardelid; P Waight; J Ellis; A Bermingham; M Zambon; B Evans; R Salmon; J McMenamin; B Smyth; M Catchpole; Jm Watson
Journal:  Euro Surveill       Date:  2010-05-20

2.  Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes.

Authors:  N Lee; C S Cockram; P K S Chan; D S C Hui; K W Choi; J J Y Sung
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

3.  Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-11-13

4.  Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.

Authors:  Alexia Campbell; Rachel Rodin; Rhonda Kropp; Yang Mao; Zhiyong Hong; Julie Vachon; John Spika; Louise Pelletier
Journal:  CMAJ       Date:  2010-02-16       Impact factor: 8.262

5.  Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-05

6.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Authors:  Bin Cao; Xing-Wang Li; Yu Mao; Jian Wang; Hong-Zhou Lu; Yu-Sheng Chen; Zong-An Liang; Lirong Liang; Su-Juan Zhang; Bin Zhang; Li Gu; Lian-He Lu; Da-Yan Wang; Chen Wang
Journal:  N Engl J Med       Date:  2009-12-09       Impact factor: 91.245

7.  Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.

Authors:  Ryan Zarychanski; Tammy L Stuart; Anand Kumar; Steve Doucette; Lawrence Elliott; Joel Kettner; Frank Plummer
Journal:  CMAJ       Date:  2010-01-21       Impact factor: 8.262

8.  H1N1 2009 influenza virus infection during pregnancy in the USA.

Authors:  Denise J Jamieson; Margaret A Honein; Sonja A Rasmussen; Jennifer L Williams; David L Swerdlow; Matthew S Biggerstaff; Stephen Lindstrom; Janice K Louie; Cara M Christ; Susan R Bohm; Vincent P Fonseca; Kathleen A Ritger; Daniel J Kuhles; Paula Eggers; Hollianne Bruce; Heidi A Davidson; Emily Lutterloh; Meghan L Harris; Colleen Burke; Noelle Cocoros; Lyn Finelli; Kitty F MacFarlane; Bo Shu; Sonja J Olsen
Journal:  Lancet       Date:  2009-07-28       Impact factor: 79.321

9.  Critically Ill patients with 2009 influenza A(H1N1) in Mexico.

Authors:  Guillermo Domínguez-Cherit; Stephen E Lapinsky; Alejandro E Macias; Ruxandra Pinto; Lourdes Espinosa-Perez; Alethse de la Torre; Manuel Poblano-Morales; Jose A Baltazar-Torres; Edgar Bautista; Abril Martinez; Marco A Martinez; Eduardo Rivero; Rafael Valdez; Guillermo Ruiz-Palacios; Martín Hernández; Thomas E Stewart; Robert A Fowler
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

10.  Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis.

Authors:  Santiago Echevarría-Zuno; Juan Manuel Mejía-Aranguré; Alvaro J Mar-Obeso; Concepción Grajales-Muñiz; Eduardo Robles-Pérez; Margot González-León; Manuel Carlos Ortega-Alvarez; Cesar Gonzalez-Bonilla; Ramón Alberto Rascón-Pacheco; Víctor Hugo Borja-Aburto
Journal:  Lancet       Date:  2009-11-11       Impact factor: 79.321

View more
  69 in total

1.  Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.

Authors:  Manjunath P Pai; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Children with special health care needs and preparedness: experiences from seasonal influenza and the 2009 H1N1 influenza pandemic.

Authors:  Georgina Peacock; Cynthia Moore; Timothy Uyeki
Journal:  Disaster Med Public Health Prep       Date:  2012-06       Impact factor: 1.385

3.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

5.  Effect of rapid influenza diagnostic testing on antiviral treatment decisions for patients with influenza-like illness: southwestern U.S., May-December 2009.

Authors:  Anil Suryaprasad; John T Redd; Philip M Ricks; Laura Jean Podewils; Meghan Brett; Jane Oski; Wanda Minenna; Frank Armao; Barbara J Vize; James E Cheek
Journal:  Public Health Rep       Date:  2014 Jul-Aug       Impact factor: 2.792

Review 6.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

7.  Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Authors:  Peng Yang; Li Zhang; Weixian Shi; Guilan Lu; Shujuan Cui; Xiaomin Peng; Daitao Zhang; Yimeng Liu; Huijie Liang; Xinghuo Pang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2011-12-30       Impact factor: 4.380

Review 8.  Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy.

Authors:  Eric J Chow; Richard H Beigi; Laura E Riley; Timothy M Uyeki
Journal:  Open Forum Infect Dis       Date:  2021-03-20       Impact factor: 3.835

9.  Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.

Authors:  Suizan Zhou; Carolyn M Greene; Ying Song; Ran Zhang; Lance E Rodewald; Luzhao Feng; Alexander J Millman
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

Review 10.  Influence of obesity on clinical outcomes in hospitalized children: a systematic review.

Authors:  Lori J Bechard; Pamela Rothpletz-Puglia; Riva Touger-Decker; Christopher Duggan; Nilesh M Mehta
Journal:  JAMA Pediatr       Date:  2013-05       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.